Download presentation
Presentation is loading. Please wait.
Published byJustin Harmon Modified over 9 years ago
1
(DNA-based) cell targeting
2
Overview Goals 3 designs Possible Implementation Future directions
3
Goal (what we want) Control of substrate delivery to a cell. –What substrates? Proteins, sugars, DNA [nanostructures]. –What kind of control? Amount that gets to the cell surface, amount relative to other proteins targeted to cell. –Potentially important application in drug delivery, nanostructures.
4
AB C Design options
5
A: Aptamer-based Good: –It’s simple. –It’s been done before with success. Bad: –Requires design of different aptamer sequences that can bind to cell-surface protein. 2 associations
6
B: Biotin/Streptavidin Good: –Depends on association b/w biotin and streptavidin. –Able to swap in and out target proteins. Bad: –Depends on association b/w biotin-streptavidin interaction Ugly: –Complexity –Expressing streptavidin on cell surface using OmpX Nevertheless, proof of principle! 4 associations
7
C: DNA-base pairing Good: –Control of relative amounts of protein that bind cell 3 associations
8
Control of relative amounts? DNA bound cell surface: ATCATC Sequence conjugated to substrate A: TAGTAG Sequence conjugated to substrate B: TAG Substrate A binds less often but for longer periods of time. Precise control of kinetics based on types of base-pairs used; repeated patterns.
9
C: DNA-base pairing Good: –Control of relative amounts of protein that bind cell. Bad: –If we can control amount of aptamer bound to cell surface, probably can get as much/ better control by delivering protein bound directly to the aptamer. 3 associations
10
Implementation of B Part 1: Making E. coli express streptavidin on cell surface (which would be interesting by itself). See Rice, et al. –Challenges: Is this even possible? –Assay: Test for fluorescently labeled biotin-DNA binding to cell surface. –Might attempt to evolve proteins that can do this. Time consuming!! Might start knowing that we wouldn’t finish. Part 2: Conjugate a protein to biotinylated DNA (can do in parallel) Part 3: Testing –More fluorescently labeled DNA
11
Implementation of B -Part 1: Infinite time for 3 people working on streptavidin fusion protein -Part 2 [in parallel]: 4 weeks for 2 people to work on substrate synthesis
12
Implementation of C Part 0: Figure out if it’s worth it. Part 1: Find and test aptamer that binds cell-surface protein –Literature search –Assay: use fluorescently labeled aptamer Part 2: Conjugate a protein to single stranded DNA. Part 3: Testing –Fluorescently labeled DNA again! Part 4: Determining DNA annealing properties and whether proteins can simply be swapped with predictable behavior.
13
Implementation of C Part 1: One week for literature search, one week for testing, 2 people. Part 2: [In parallel] Four weeks for two people to conjugate a protein to single stranded DNA. Part 3: One week for 2 people. Part 4: Potentially a week based on faculty answers; testing is Parts 1-3 multiplied
14
Major Questions What cell-surface protein(s) to target? What substrate do we want to use? –Eventual application? –Practicality? Can we really hope to express Streptavidin on a cell surface in a summer? How does this fit into iGEM? Where are we going with this?
15
Future directions Use aptamers to trigger signaling cascades; finer control of gene expression. Create a dock for a DNA nanostructure
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.